Summit Asset Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Summit Asset Management's LLY Position: Q1 2026 in Review
Summit Asset Management reduced its Eli Lilly (LLY) stake by 0.14% in Q1 2026, selling an estimated $2.03K and leaving 1,384 shares worth $1.27M. The position accounts for 0.18% of the portfolio, ranked #63.
Summit Asset Management first reported a position in LLY in Q3 2020 and has held it in 22 quarters since. The position peaked at $1.49M in Q4 2025. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Summit Asset Management held 1,384 shares of Eli Lilly worth $1.27M as of Q1 2026.
- Summit Asset Management sold 2 Eli Lilly shares in Q1 2026, an estimated $2.03K.
- Eli Lilly made up 0.18% of Summit Asset Management's portfolio in Q1 2026, its #63 holding.
- Summit Asset Management first reported a position in Eli Lilly in Q3 2020 and has held it in 22 quarters since.
- Summit Asset Management's Eli Lilly position peaked at $1.49M in Q4 2025.
- 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Summit Asset Management's 13F filing for Q1 2026, filed 8 May 2026.